The research involved assessing the Psoriasis Area Severity Index (PASI), the spleen-to-body weight ratio, and the expression levels of TLR4 and NF-κB using immunohistochemical techniques in a mouse model. The gene discussed is NFKB1; the disease is psoriasis.